TokenPost·
Regeneron and Alnylam Win FDA Approval for Livsayis in Adults

The RNA therapeutic, identified as Livsayis (cemdisiran), was approved to treat adults with myasthenia gravis, a chronic autoimmune condition.
Every crypto headline. One feed. Updated every minute.

The RNA therapeutic, identified as Livsayis (cemdisiran), was approved to treat adults with myasthenia gravis, a chronic autoimmune condition.